Reckitt Benckiser Group PLC ADR (RBGLY)
Reckitt Benckiser Group PLC ADR is a depositary receipt representing common stock of Reckitt Benckiser Group plc, which trades on OTC Markets under the symbol RBGL.Y. The underlying company develops and sells health, hygiene, and nutrition products across the United Kingdom and international markets. Its portfolio includes germ protection products sold under Dettol; intimate wellness brands such as Durex and KY; over-the-counter remedies including Biofreeze, Gaviscon, Mucinex, Nurofen, Delsym, Cepacol, and Strepsils; personal care products under Clearasil and Veet; and vitamins, minerals, and supplements marketed as MegaRed, Airborne, Digestive-Advantage, Movefree, and neuriva. The company also sells stain removal products under Vanish, disinfectants under Finish, Harpic, and Lysol, and infant and young child nutrition products under Enfamil and Nutramigen. Reckitt Benckiser Group plc was founded in 1819 and is headquartered in Slough, United Kingdom.
Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.
| Ticker | Fair Value | Fair Value Upside/Downside | Fair Value Rating | Analyst Price Target | Analyst Target Upside/Downside | Analyst Target Rating | Overall Financial Health | Upcoming Dividend Ex-Date | Dividend Payment Date | Upcoming Dividend | Dividend Yield | Next Earnings Date | P/E Ratio | Price-to-Book Ratio | Price-to-Sales Ratio | Market Cap | Enterprise Value | Total Debt / Total Capital | Free Float / Shares Outstanding | Altman Z-Score | Payout Ratio | Free Cash Flow / Net Income |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
OTC-RBGL.Y
|
$17.03
|
27.3% Upside
|
Undervalued
|
$16.63
|
24.3% Upside
|
Undervalued
|
Good
|
—
|
—
|
1.12
|
4.6%
|
—
|
10.1x
|
4.2x
|
2.3x
|
43.182 B
|
52.344 B
|
20.9%
|
99.2%
|
13.7
|
44.1%
|
55.1%
|